×
Entrez Id: 7157
Gene Symbol: TP53
TP53
Mammary Neoplasms, Human
0.500
Biomarker
CTD_human
Worse survival for TP53 (p53)-mutated breast cancer patients receiving adjuvant CMF.
15802278 2005
×
Entrez Id: 7157
Gene Symbol: TP53
TP53
Mammary Neoplasms, Human
0.500
Biomarker
CTD_human
Evaluation of the prognostic and predictive value of p53 and Bcl-2 in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy.
16968874 2006
×
Entrez Id: 7157
Gene Symbol: TP53
TP53
Mammary Neoplasms, Human
0.500
Biomarker
CTD_human
p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progression.
30381462 2018
×
Entrez Id: 7157
Gene Symbol: TP53
TP53
Mammary Neoplasms, Human
0.500
Biomarker
CTD_human
The oncoprotein HBXIP modulates the feedback loop of MDM2/p53 to enhance the growth of breast cancer.
26229107 2015
×
Entrez Id: 4312
Gene Symbol: MMP1
MMP1
Mammary Neoplasms, Human
0.500
Biomarker
CTD_human
Matrix metalloproteinase Mmp-1a is dispensable for normal growth and fertility in mice and promotes lung cancer progression by modulating inflammatory responses.
23548910 2013
×
Entrez Id: 7157
Gene Symbol: TP53
TP53
Mammary Neoplasms, Human
0.500
Biomarker
CTD_human
Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen.
17388661 2007
×
Entrez Id: 7157
Gene Symbol: TP53
TP53
Mammary Neoplasms, Human
0.500
Biomarker
CTD_human
Genomic landscape of cutaneous T cell lymphoma.
26192916 2015
×
Entrez Id: 167465
Gene Symbol: ZNF366
ZNF366
Mammary Neoplasms, Human
0.500
Biomarker
CTD_human
DC-SCRIPT: nuclear receptor modulation and prognostic significance in primary breast cancer.
20008677 2010
×
Entrez Id: 1435
Gene Symbol: CSF1
CSF1
Mammary Neoplasms, Human
0.310
Biomarker
CTD_human
Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts.
16618760 2006
×
Entrez Id: 1588
Gene Symbol: CYP19A1
CYP19A1
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer.
28112739 2017
×
Entrez Id: 9185
Gene Symbol: REPS2
REPS2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
TMEM25, REPS2 and Meis 1: favourable prognostic and predictive biomarkers for breast cancer.
19776672 2009
×
Entrez Id: 11118
Gene Symbol: BTN3A2
BTN3A2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.
29915430 2018
×
Entrez Id: 60626
Gene Symbol: RIC8A
RIC8A
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.
29915430 2018
×
Entrez Id: 50618
Gene Symbol: ITSN2
ITSN2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Expression profiling identifies genes that predict recurrence of breast cancer after adjuvant CMF-based chemotherapy.
18925433 2009
SERPINB5
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
5-Aza-2'-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation.
16799634 2007
×
Entrez Id: 1588
Gene Symbol: CYP19A1
CYP19A1
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Associations between aromatase CYP19 rs10046 polymorphism and breast cancer risk: from a case-control to a meta-analysis of 20,098 subjects.
23342035 2013
×
Entrez Id: 57561
Gene Symbol: ARRDC3
ARRDC3
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1.
25038754 2014
×
Entrez Id: 4843
Gene Symbol: NOS2
NOS2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Nitric oxide produced by inducible nitric oxide synthase is associated with mammary tumorigenesis in irradiated rats.
15631943 2005
×
Entrez Id: 6160
Gene Symbol: RPL31
RPL31
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
An integrative approach to identify YB-1-interacting proteins required for cisplatin resistance in MCF7 and MDA-MB-231 breast cancer cells.
21466612 2011
×
Entrez Id: 6423
Gene Symbol: SFRP2
SFRP2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer.
18283316 2008
×
Entrez Id: 4851
Gene Symbol: NOTCH1
NOTCH1
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.
21679465 2011
×
Entrez Id: 6514
Gene Symbol: SLC2A2
SLC2A2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Increased transglutaminase 2 and GLUT-1 expression in breast tumors not susceptible to chemoprevention with antioxidants.
19579870 2009
×
Entrez Id: 8863
Gene Symbol: PER3
PER3
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Deletion of the PER3 gene on chromosome 1p36 in recurrent ER-positive breast cancer.
20625127 2010
×
Entrez Id: 3476
Gene Symbol: IGBP1
IGBP1
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
α4 is highly expressed in carcinogen-transformed human cells and primary human cancers.
21339737 2011
ZNF667-AS1
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Epigenetic Silencing of MORT Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes.
28690657 2017